Skip to main content
OpenTrials

Clinical trial condition

Chronic Lymphocytic Leukemia (CLL)

Explore clinical trials studying Chronic Lymphocytic Leukemia (CLL). Study availability and eligibility vary by location and protocol.

72 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia (CLL) trial results

Completed

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT01647971

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +33 more
Locations
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Jonesboro, Arkansas, United States
  • TG Therapeutics Investigational Trial Site Athens, Georgia, United States
  • TG Therapeutics Investigational Trial Site Macon, Georgia, United States
View Trial Details
Completed

informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia

NCT02582879

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Northwest Alabama Cancer Center, PC Muscle Shoals, Alabama, United States
  • Arizona Oncology Associates, PC - HAL Glendale, Arizona, United States
  • Arizona Oncology Associates, PC - HAL Phoenix, Arizona, United States
View all 192 locations
View Trial Details
Completed

Study Evaluating Venetoclax in Subjects With Hematological Malignancies

NCT02265731

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +30 more
Locations
  • NHO Nagoya Medical Center /ID# 129222 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 129061 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 129278 Nagoya, Aichi-ken, Japan
  • University of Fukui Hospital /ID# 165801 Yoshida-gun, Fukui, Japan
View all 14 locations
View Trial Details
Completed

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

NCT01188681

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • For additional information regarding sites for this trial call (919) 465-4648 Denver, Colorado, United States
  • For additional information regarding sites for this trial call (919) 465-4648 Augusta, Georgia, United States
  • For additional information regarding sites for this trial call (919) 465-4648 Chicago, Illinois, United States
  • For additional information regarding sites for this trial call (919) 465-4648 Hackensack, New Jersey, United States
View all 25 locations
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

NCT02580552

Conditions
Adult T-Cell Leukemia/Lymphoma (ATLL), Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +29 more
Locations
  • City of Hope Duarte, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Center at University of California, Irvine Orange, California, United States
View all 19 locations
View Trial Details

Related conditions